Retirement Income Solutions’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$200K Hold
1,186
0.03% 170
2026
Q1
$200K Hold
1,186
0.03% 171
2025
Q4
$200K Buy
+1,186
New +$193K 0.03% 167
2024
Q2
Sell
-2,087
Closed -$286K 149
2024
Q1
$286K Buy
2,087
+41
+2% +$5.6K 0.06% 112
2023
Q4
$278K Hold
2,046
0.07% 108
2023
Q3
$250K Hold
2,046
0.07% 109
2023
Q2
$260K Hold
2,046
0.07% 114
2023
Q1
$264K Hold
2,046
0.08% 112
2022
Q4
$269K Hold
2,046
0.09% 99
2022
Q3
$241K Hold
2,046
0.09% 98
2022
Q2
$241K Buy
+2,046
New +$243K 0.09% 94
2022
Q1
Sell
-1,892
Closed -$289K 118
2021
Q4
$289K Hold
1,892
0.08% 95
2021
Q3
$306K Hold
1,892
0.1% 84
2021
Q2
$310K Sell
1,892
-1,620
-46% -$250K 0.11% 82
2021
Q1
$529K Hold
3,512
0.18% 58
2020
Q4
$532K Hold
3,512
0.19% 59
2020
Q3
$476K Hold
3,512
0.21% 55
2020
Q2
$480K Buy
+3,512
New +$448K 0.2% 55

Other funds holding IBB

Retirement Income Solutions's IBB Position: Q2 2026 in Review

Retirement Income Solutions held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 1,186 shares worth $200K. The position accounts for 0.03% of the portfolio, ranked #170.

Retirement Income Solutions first reported a position in IBB in Q2 2020 and has held it in 18 quarters since. The position peaked at $532K in Q4 2020. 955 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Retirement Income Solutions held 1,186 shares of iShares Biotechnology ETF worth $200K as of Q2 2026.
  • Retirement Income Solutions left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.03% of Retirement Income Solutions's portfolio in Q2 2026, its #170 holding.
  • Retirement Income Solutions first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 18 quarters since.
  • Retirement Income Solutions's iShares Biotechnology ETF position peaked at $532K in Q4 2020.
  • 955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Retirement Income Solutions's 13F filing for Q2 2026, filed 3 Aug 2026.